Skip To Main Content
Katherine E. Fleming-Dutra on Muck Rack

Katherine E. Fleming-Dutra

As seen in: Center for Disease Control and Prevention, Wiley Online Library, JAMA (The Journal of the American Medical Association), JAMA: Journal of the American Medical Association, The New England Journal of Medicine, Medscape, Pediatrics, Healio, Healio Cardiac/Vascular Intervention, Infectious Diseases News and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Katherine E.

Contact Katherine E., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS‐CoV‐2 Infection-Increasing Community Access to Testing Program, United States, January-September 2023 - Ciesla - 2024 - Influenza and Other Respiratory Viruses - Wiley Online Library

|
By Allison Avrich Ciesla, Josephine Mak, Lauren Roper, Katherine E. Fleming-Dutra
| Wiley Online Library Verified
1 Introduction On September 2, 2022, bivalent COVID-19 mRNA vaccines, composed of components from the SARS-CoV-2 ancestral and Omicron BA.4/BA.5 strains, were recommended by the Advisory Committee on Immunization Practices (ACIP) to address reduced effectiveness of COVID-19 monovalent vaccines during SARS-CoV-2 Omicron variant predominance [1].
Open in Who Shared Issue with article?

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United St

|
By Katherine E. Fleming-Dutra
| CDC Featured Podcasts
Early Release / October 6, 2023 / 72 Katherine E. Fleming-Dutra, MD1,*; Jefferson M. Jones, MD1,*; Lauren E. Roper, MPH1; Mila M. Prill, MSPH1; Ismael R. Ortega-Sanchez, PhD1; Danielle L. Moulia, MPH1; Megan Wallace, DRPH1; Monica Godfrey, MPH1; Karen R. Broder, MD2; Naomi K. Tepper, MD3; Oliver Brooks, MD4; Pablo J. Sánchez, MD5; Camille N. Kotton, MD6; Barbara E. Mahon, MD1; Sarah S. Long, MD7; Meredith L.
Open in Who Shared Issue with article?

Messenger RNA Vaccine in Mother’s Milk

|
By Jennifer Nelson, Katherine E. Fleming-Dutra, Respiratory Diseases, Dana Meaney-Delman
| JAMA (The Journal of the American Medical Association) Verified
Messenger RNA Vaccine in Mother’s Milk Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk Nazeeh Hanna, MD; Ari Heffes-Doon, MD; Xinhua Lin, PhD; Claudia Manzano De Mejia, MD; Bishoy Botros, BS; Ellen Gurzenda, BS; Amrita Nayak, MD Messenger RNA Vaccine in Mother’s Milk—Reply Nazeeh Hanna, MD; Christie Clauss, PharmD; Leonard R. Krilov, MD To the Editor After reading the article by Hanna et al,1 we had concerns with their conclusions that do not seem to be supported by the data.
Open in Who Shared Issue with article?
See all 29 licensed articles (48 Total)